Department of Endocrinology and Metabolism, St. Paul's Hospital, Vancouver, British Columbia, Canada.
Diabetes Care. 2010 Aug;33(8):1738-40. doi: 10.2337/dc09-2256.
To assess the effect of an Internet-based glucose monitoring system (IBGMS) on A1C levels in patients with type 2 diabetes treated with insulin.
This trial involved 50 patients randomly assigned to receive either conventional treatment alone or with additional follow-up through an IBGMS for 6 months. Patients randomized to the intervention group uploaded blood glucose readings every 2 weeks to a secure Web site for review and receipt of feedback from their endocrinologist. A1C and laboratory test results were collected at 0, 3, and 6 months.
The baseline parameters were not significantly different. Over a 6-month follow-up, A1C dropped from 8.8 to 7.6% (P < 0.001) in the intervention group compared with 8.5 to 8.4% (P = 0.51) in the control group.
The use of IBGMS significantly improved A1C levels in patients with type 2 diabetes treated with insulin.
评估基于互联网的血糖监测系统(IBGMS)对接受胰岛素治疗的 2 型糖尿病患者 A1C 水平的影响。
本试验纳入了 50 名患者,随机分为仅接受常规治疗组或在常规治疗的基础上通过 IBGMS 进行额外 6 个月随访的治疗组。随机分配到干预组的患者每两周上传一次血糖读数,以便内分泌医生审查并提供反馈。在 0、3 和 6 个月时收集 A1C 和实验室检测结果。
基线参数无显著差异。在 6 个月的随访中,干预组的 A1C 从 8.8%降至 7.6%(P<0.001),而对照组从 8.5%降至 8.4%(P=0.51)。
在接受胰岛素治疗的 2 型糖尿病患者中,使用 IBGMS 可显著改善 A1C 水平。